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BACKGROUND: In 2003, Project ECHO (Extension for
Community Healthcare Outcomes) began using
technology-enabled collaborative models of care to help
general practitioners in rural settings manage hepatitis C.
Today, ECHO and ECHO-like models (EELM) have been
applied to a variety of settings and health conditions, but
the evidence base underlying EELM is thin, despite widespread enthusiasm for the model.
METHODS: In April 2018, a technical expert panel (TEP)
meeting was convened to assess the current evidence
base for EELM and identify ways to strengthen it.
RESULTS: TEP members identified four strategies for
future implementors and evaluators of EELM to address
key challenges to conducting rigorous evaluations: (1)
develop a clear understanding of EELM and what they
are intended to accomplish; (2) emphasize rigorous
reporting of EELM program characteristics; (3) use a
wider variety of study designs to fill key knowledge gaps
about EELM; (4) address structural barriers through capacity building and stakeholder engagement.
CONCLUSIONS: Building a strong evidence base will help
leverage the innovative aspects of EELM by better understanding how, why, and in what contexts EELM improve
care access, quality, and delivery, while also improving
provider satisfaction and capacity.
KEY WORDS: telemedicine; telehealth; Project ECHO; evaluation; evidence
base; distance learning; continuing medical education; capacity building.
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INTRODUCTION

A growing number of health care organizations and primary
care practitioners across the U.S. and the world have implemented models of care delivery using technology-enabled
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collaborative learning to build provider capacity. Such models
are designed to help clinicians deliver care to patients with
conditions that are within their scope of practice but they feel
less prepared to handle. The first known example, Project
ECHO (Extension for Community Healthcare Outcomes), is
a hub-and-spoke model connecting generalists in one or more
locations (“spokes”) with specialists at a different location (the
“hub”) through videoconferencing sessions, which typically
include a didactic component and deidentified case presentations and discussions (Fig. 1). Project ECHO launched in 2003
in New Mexico with a focus on supporting hepatitis C virus
(HCV) management by primary care physicians in rural regions of the state. Since then, adaptations of this model have
been implemented in many different locations and settings,
addressing a wide range of conditions and topics, including
tuberculosis, addiction, and antibiotic stewardship. We refer to
these technology-enabled collaborative learning models of
care delivery as ECHO and ECHO-like models (EELM).
A 2011 study describing the impact of Project ECHO on
HCV outcomes in New Mexico1 generated enthusiasm for
EELM, which led to a rapid increase in both the number of
EELM programs and the number of clinical topics they address. Despite this momentum, the evidence base for their
impact on key patient and provider outcomes remains limited.
In part, this may be because many implementation efforts have
focused on diffusing variations on the model rather than
systematically evaluating them.
In December 2016, Congress passed the Expanding Capacity for Health Outcomes Act (“ECHO Act”), requiring an
evaluation of the evidence base for technology-enabled collaborative models of care.2 As part of this evaluation, the
Office of the Assistant Secretary for Planning and Evaluation
(ASPE) in the U.S. Department of Health and Human Services
contracted with the RAND Corporation to facilitate a technical
expert panel (TEP) meeting, which occurred on April 9, 2018,
in Washington, DC. Participants are listed in Online Appendix
A. The goal of the meeting was to assess the evidence base for
EELM and identify opportunities to expand it. TEP members
were asked to consider the following questions: (1) given what
is currently known about the effectiveness of EELM, what are
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Figure 1 Key components of EELM (Sources for graphics: Noun Project/MRFA; danishicon; Samy Menai; Gregor Cresnar; Creative Stall).

the knowledge gaps to be addressed?, (2) why do these gaps
exist, and (2) how could those gaps best be filled? In preparation for the TEP meeting, RAND researchers developed an
inventory of EELM, conducted a systematic review of published evaluations of EELM, and conducted semi-structured
discussions with key informants implementing EELM, selected to ensure diversity by geography and health conditions
addressed, which were synthesized into nine case studies.
These materials were shared with the TEP before the meeting
as a basis for discussion.
This article summarizes the meeting’s findings, beginning with
a description of the knowledge gaps around EELM. Next, the
TEP members identified challenges to conducting rigorous evaluations that help explain why the knowledge gaps exist. These
challenges are grouped into four categories, and for each category, options to overcome these challenges are presented.

NUMEROUS KNOWLEDGE GAPS AROUND EELM BUT
ENTHUSIASM FOR ITS PROMISE

TEP members agreed that the central question about EELM is
whether “it works,” but that there are other important knowledge gaps that exist. TEP members generated numerous potential research questions related to, for instance, implementation and dissemination; impacts on patient, provider, and
system outcomes; and impacts on population health and health
equity (Online Appendix B). The TEP distilled these potential
research areas down to four overarching questions to guide
future evaluation efforts (Table 1).
TEP members noted that most existing evidence around EELM
concerns provider satisfaction with participating in an EELM
program and the extent to which knowledge and self-efficacy
improved. Focusing in future evaluations on measuring patient
outcomes, expanded definitions of provider satisfaction and engagement, and care processes that could affect system-level improvements (e.g., decreased wait times, lower costs) would

significantly strengthen the evidence base for EELM, and these
four priority questions shown in Table 1 offer a starting point.
Finally, while they recognized that the evidence base needs
strengthening, the TEP stressed the importance of acknowledging providers’ enthusiasm for the promise of EELM. The
implementation of these models in various contexts indicates
that there is significant demand for this approach, and better
understanding what is driving this demand would help guide
the design of future evaluations. Thus, TEP members cautioned against interpreting the relatively weak evidence base
as evidence that EELM is ineffective.

WHY THESE KNOWLEDGE GAPS EXIST: CHALLENGES
AND POTENTIAL OPTIONS TO ADDRESS THEM

The TEP discussion generated four key categories of challenges
to strengthening the evidence base for EELM as well as potential
options to address each of these challenges (Table 2). TEP
members noted that the options require coordination and ongoing
engagement among multiple stakeholders, including implementors and evaluators of EELM, funders, and policymakers.
1. Diversity of intended purposes of EELM: TEP members
commented that, as EELM have expanded to encompass
a range of conditions beyond HCV, it has become clear
that they can serve a variety of purposes. Two of these
include improving access to care often provided by
specialists and improving the quality of care for more
common conditions such as depression. In short, a
Table 1 Overarching Questions About EELM
• What is the evidence for the impact of EELM on patient health?
• Across which conditions are EELM most effective in improving
patient health?
• For which conditions do EELM provide the most value
(improved outcomes relative to cost)?
• To what degree do EELM achieve their intended purpose(s)?
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Table 2 Challenges to Conducting Rigorous Evaluations of EELM and Potential Options to Address Them
Challenge

Potential options to address the challenge

Summary actions

1: Diversity of intended
purposes of EELM

a: Build consensus around the definition and purposes of EELM
b: Evaluation outcomes should reflect intended purposes of EELM

Develop a clear understanding of EELM

2: Variable implementation
of the model

a: Programs should document details of model implementation

Emphasize rigorous reporting of program
characteristics and implementation

3: Limited use of variety of
study designs

a: Consider strategies to facilitate randomization
b: Leverage non-randomized study designs that have advantages
over study designs that have been used to date
c. Choose meaningful comparators
d: Document persistence or waning of effects of EELM over time,
and spillover into other patients that were not presented as cases

Use a wider variety of study designs

4: Structural barriers to
high-quality evaluation

a: Support sustainable funding streams for EELM evaluations
b: Enlist champions to support evaluations of EELM
c: Provide technical assistance and build capacity to conduct
evaluations of EELM
d: Support data-sharing and interoperability

Provide technical assistance and build capacity;
engage with policymakers and funders

challenge to evaluating whether EELM “work” is a lack
of consensus among stakeholders on the intended
objectives of these programs and how achievement of
these objectives can best be evaluated. Given the
diversity of intended purposes of EELM, it will be
important for future evaluators to devise both a core set
of outcomes to measure across types of EELM (e.g.,
retention of physician-participants), as well as contextspecific metrics that are appropriate to the intended
purpose(s) of the program being studied (e.g., processes
and outcomes for a particular condition).
2. Variable implementation of the model: EELM have been
implemented in diverse ways, varying in their design with
respect to the original Project ECHO model and intended
for a wide range of clinical conditions and populations.
Thus, it is important that evaluations document both
characteristics of the intervention itself as well as its
implementation (i.e., fidelity to the model versus adaptation). Without collecting data on how EELM are implemented in different contexts (e.g., number of intended and
actual telementoring sessions conducted and duration,
types of providers participating, retention rate), it is
difficult to assess which aspects of the model contribute
to success and how to generalize evaluation findings.
3. Limited use of a variety of possible study designs for rigorous
evaluation, leading to less confidence in evaluations: Most
existing studies of EELM have used a pre-post design without
a comparator, which could lead to conclusions that EELM are
effective for many situations in which a different intervention
might have been more effective. The panel suggested
potential comparators that could be used in different contexts.
For example, programs focusing on supporting generalists in
managing complex cases of a common condition might be
compared with a continuing medical education webinar. A

program seeking to expand access to care for a rarer condition
typically managed by specialists might compare EELM with
telemedicine.
Furthermore, existing evaluations have been conducted over
short time frames; little is known about whether EELM
continue to be effective beyond the study period or whether
provider knowledge gained through EELM “decays” over
time. Evaluators may want to consider additional assessments after the intervention ends to capture whether and
when this decay occurs, and how to prevent it. In addition, it
is not known the extent to which knowledge gained through
case presentations better equips providers to treat patients
who were not discussed during EELM sessions.

Thus far, evaluations have been unable to definitively show
that EELM improve patient, provider, and system outcomes or
put more simply that “it works.” The RAND team assessed the
quality of existing EELM evaluations using the Grading of
Recommendations Assessment, Development, and Evaluation
(GRADE) framework as “low” or “very low” for the outcomes
of interest, and TEP members concurred. While this level of
evidence is not unusual for innovations in health care delivery,
there are opportunities to increase the rigor of EELM evaluations. Specifically, alternatives to traditional randomized controlled trials, which can be challenging and expensive to
implement in real-world settings, include other experimental
and quasi-experimental designs, such as crossover, nonplacebo-controlled parallel, or stepped-wedge, as well as
non-randomized designs such as pre-post intervention with a
control group. Mixed-method evaluations with a qualitative
component should also be considered. For example, in-depth
interviews could provide context for measured outcomes and
elicit perspectives on the importance of charismatic leaders,
characteristics of high-functioning teams, and quality and
relevance of specialists’ recommendations.
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4. Structural barriers to high-quality evaluation: As with
evaluations of other innovations in health care delivery,
there are several structural barriers to high-quality evaluation of EELM. These include a focus on implementation
and a lack of resources devoted to evaluation, lack of
internal expertise to conduct rigorous evaluations using a
wider variety of study designs noted above, limited access to
high-quality data, and lack of clarity on appropriate outcome
measures and how they can be operationalized. Addressing
these barriers requires garnering the technical and financial
support needed to carry out higher quality studies. Efforts
could include creating sustainable funding streams with
resources for rigorous evaluation; leveraging efforts to
improve data interoperability and exchange at various levels
(hubs, local, state, and federal); harnessing the enthusiasm
of EELM champions among administrative and clinical
leaders so that EELM activities and evaluations receive
appropriate prioritization and funding; and establishing
resource centers to provide tools and technical assistance
to EELM programs in order to conduct evaluations.

and system-level outcomes of interest, include appropriate
comparators, and extend the time frames of evaluations.
4. To address structural barriers to rigorous evaluations of
EELM, provide technical assistance and build evaluation
capacity, when additional expertise would be beneficial. In
addition, engage with policymakers, funders, and other
stakeholders to gain support and funding for conducting
evaluations. Implementors and evaluators need to explore
mutually beneficial mechanisms for supporting rigorous
evaluation to expand the evidence base for EELM.

The TEP members’ assessment of the evidence base for
EELM and suggestions for strengthening it informed the development of a public report3 submitted to Congress by ASPE,
responding to the ECHO Act.
Project ECHO celebrated its 15th anniversary in 2018, and
EELM continues to be implemented in various settings. Welldesigned evaluations can help policymakers, researchers, and
clinicians understand how EELM can be effective and in what
contexts, thereby identifying to what extent these models can
contribute to expanding access to care, improving quality,
building provider capacity, and enhancing health care delivery
to underserved populations.

CONCLUSIONS

TEP members assessed EELM’s evidence base and identified
multiple ways to better understand EELM’s benefits and limitations. To address four key challenges to conducting rigorous
evaluations of these promising models, the following overarching strategies were viewed as critical to developing
EELM’s evidence base:
1. Develop a clear understanding of EELM, what they are
intended to accomplish, and the critical components of
EELM that are necessary to meet their goals. Evaluators
must recognize the diversity of EELM and how they
vary in their design with respect to the original Project
ECHO model, sometimes reflecting the particular health
conditions and objectives addressed by a given EELM.
They should also attempt to identify the core desired
outcomes of EELM and how to measure them through
evaluations.
2. Emphasize rigorous reporting of EELM program characteristics. Reporting on a broader set of EELM program
characteristics would elucidate variations of the model in
practice and what “ingredients” may lead to better outcomes
for various conditions and program objectives.
3. Focus on the four overarching questions identified above,
and use a wider variety of study designs to fill the
numerous knowledge gaps about EELM. There are many
potential research questions about EELM, and the TEP
identified a small number of broad questions to guide
future evaluation efforts. To rigorously answer these
questions, there are opportunities to employ a variety of
study designs, more clearly define the patient-, provider-,
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